The suppressed expression and activity of Nrf2 and HO-1 has been revealed in COPD mouse model [23] and some drugs, such as metformin and alantolactone, have been shown to relieve COPD by activating the Nrf2/HO-1 pathway [22, 28]. Here, NFE2L2 is linked to chronic obstructive pulmonary disease.